ERBB2 and cancer: Similarly, Sasaki et al. [20] argued that HER2 protein measurement in serum cannot substitute diagnosis of HER2 abnormalities in cancer tissue in advanced gastric cancer patients, despite that they indicated correlation between protein expression in tissue and in serum.